Disease activity, cumulative damage and quality of life systematic lupus erythematosus: Results of a cross-sectional study

Lupus

Volumn 6, Issue 3, 1997, Pages 243-247

  Hanly, J G ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Damage; Disease activity; Lupus; Quality of life; SLE

Indexed keywords

ADULT; AGED; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0030889831     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339700600305     Document Type: Article

References (24)

1. Ginzler E, Berk A. Mortality in systemic lupus erythematosus J Rheumatol 1987; 14: 218-222.
2. Swaak AJG et al 1989; Systematic lupus erythematosus. 1. Outcome and survival: Dutch experience with 110 patients studied prospectively. Ann Rheum Dis 48: 447-454.
3. Gladman DD Prognosis of SLE and factors that affect it. Curr Opin Rheumatol 1992, 3: 789-796.
4. Fries JF, Spitz PW The hierarchy of patient outcomes In: Spilker B (ed) Quality of Life Assessment in Clinical Trials Raven Press, New York 1990; 2535.
5. Burckhardt C, Archenholtz B, Bjelle A Quality of life of women with systematic lupus erythematosus. a comparison with women with rheumatoid arthritis. J Rheumatol 1993; 20: 977-981.
6. Symmonds DPM et al. Development and assessment of a computerized index of clinical disease activity in systemic lupus erythematosus. Quart J Med 1988; 69: 927-937.
7. Liang MH, Socher SA, Larsen MG, Schur PH. 1989; Reliability and validity of 6 systems for the clinical assessment of disease activity in SLE. Arthritis Rheum 1989; 32: 1107-1118
8. Bombardier C et al. and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI a disease index (SLEDAI) for lupus patients. Arthritis Rheum 1992; 35: 630-640.
9. Bombardieri S et al. Activity criteria in systemic lupus erythematosus. Lupus 1995; 4: 5
10. Gladman DD dD et al. Cross-cultural validation and reliability of three disease activity indices in SLE J Rhematol 1992; 19: 608-611.
11. Gladman DD et al Sensitivity to change of three SLE disease activity indices international validation (abstract). Arthritis Rheum 1990; 33 (suppl 9): S82.
12. Gladman DD et al. The development and initial validation of the systemic lupus international collaborating clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 363-369.
13. Gladman D et al. Derivation of a weighting scale for the SLICC/ACR damage index - primary index. Arthritis Rheum 1994, 37 (suppl 9): S326.
14. Stoll T, Seifert B, Isenberg D. SLICC/ACR damage is valid, andrenal and pulmonary organ scores are predictors of severe outcome in patients with systemic lupus erythematosus. British J Rheumatol 1996; 35: 248-254.
15. Gorgos L, Goldman D, Petri M. The ACR/SLICC Damage Index in systemic lupus erythematosus (abstract) Arthritis Rheum 1993; 36 (suppl 9): S68.
16. Urowitz M et al. Assessment of the reliability of the SLICC/ACR damage index for SLE (abstract). Arthritis Rheum 1995 38(6)): R37.
17. Tan EM et al The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
18. Stewart A, Hays R, Ware J. The MOS short-form general health survey Reliability and validity in a patient population . Medical Care 1988; 26: 724-735
19. Isenberg D, Shortall E, Newman S. Systemic lupus erythematosus disease activity, severity, treatment and costs J Rheumatol 1994; 21: 394-396.
20. Lacaille D et al. The impact of disease activity, treatment and disease severity on short term costs of systemic lupus erythematosus. J Rheumatol 1994; 21: 448-453.
21. Gordon C et al. Quality of life is influenced by disease activity but is impaired in all SLE patients . British J Rheumatol 1996; 35: 31.
22. Gordon C et al. Comparison of the SF-20 and SF-36 in the assessment of quality of life inSLE . British J Rheumatol 1996; 35: 31.
23. Middleton GD, McCfarlin JE, Lipsky PE. The prevalence and clinical impact of fibromyalgia in systemic lupus erythematosus . Arthritis Rheum 1994; 37(8): 1181-1188.
24. Hay EM et al. Psychiatric disorder and cognitive impairment in systemic lupus erythematosus. Arthritis Rheum 1992; 35(4) 411-416.